Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve financial results of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr Lalchandani Labs Ltd has informed BSE that a meeting of its Board of Directors is scheduled for May 30, 2026. The agenda includes consideration and approval of the Audited Financial Results for the half year and full year ended March 31, 2026. Additionally, the company has confirmed that the trading window under SEBI's Insider Trading Regulations will remain closed until 48 hours after the results are declared. This is a routine regulatory intimation under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No financial figures or preliminary highlights are disclosed in this filing.
This is a standard procedural notice. Investors should note that the trading window is closed, meaning insiders cannot trade until after the results are published. Actual financial performance and any associated signals will be visible only in the results filing expected around May 30, 2026.